As it does at least once a year, the National Comprehensive Cancer Network (NCCN) has just released version 1.2018 of its guidelines for physicians on the management of prostate cancer. … READ MORE …
Filed under: Management, Treatment | Tagged: guideline, NCCN, update | 4 Comments »
A new review article has provided a detailed update on the current state of knowledge about the use of sipuleucel-T (Provenge®) in the treatment of advanced forms of prostate cancer. … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: Provenge, review, sipuleucel-T, update | Leave a comment »
We apologize for the slight delay in getting to other notable news from the annual meeting of the American Society for Clinical Oncology. (Other elements of the rest of life interfered.) However, here is the keypoint summary with links to the relevant abstracts: … READ MORE …
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Risk | Tagged: ASCO, radium-223, tasquinimod, update | 5 Comments »
The August 15 issue of American Family Physician — supposedly one of the most widely read medical journals in America — carried an article by Mohan and Schellhammer entitled “Treatment options for localized prostate cancer.” Unfortunately the full text of this article is not available on line for the average reader. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: doctor, eductation, family, Management, physician, update | 4 Comments »
A multi-center research team has used data from > 7,300 radical prostatectomy patients treated between 2000 and 2005 at two major medical centers to construct a new “2010 Partin nomogram” to improve prediction of pathologic outcomes after radical surgery. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: nomogram, Partin tables, revision, update | 3 Comments »
Today’s prostate cancer update includes information on:
Filed under: Diagnosis, Living with Prostate Cancer, Management, Treatment | Tagged: "high risk", cancer, couples, infection, Management, news, outcomes, prostate, risk, sexually, transmitted, update | Leave a comment »
The ability to provide engaging and easily understood information about prostate cancer screening for low literacy popuations is a continuing challenge. Volk et al. have developed and evaluated an “entertainment-based” patient decision aid for prostate cancer screening, comparing its effectiveness among patients with low and high health literacy. … READ MORE …
Filed under: Diagnosis, Management | Tagged: cancer, education, entertainment, news, prostate, screening, update | 5 Comments »
A recent report by Rapiti et al. from the Geneva Cancer Registry documents a significant increase in risk for colon but not rectum cancer after earlier external beam radiotherapy (EBRT) for prostate cancer. While it is well known that radiotherapy can induce second cancers, there has been some controversy over the risk for second malignancies after irradiation for prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: beam, cancer, colon, colorectal, external, news, prostate, radiotherapy, update | 6 Comments »
A Reuters report issued today quotes US-based researchers as saying that men with elevated levels of calcium in their blood may have a much higher risk of getting fatal prostate cancer than the average man with a diagnosis of prostate cancer. … READ MORE …
Filed under: Diagnosis, Management, Treatment | Tagged: blood, calcium, cancer, levels, news, prostate, risk, update | Leave a comment »
Today’s reports address:
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: cancer, Gleason, localized, news, pattern, prostate, radiotherapy, tertiary, update | Leave a comment »
In today’s reports:
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: acupuncture, cancer, hormone, news, prostate, testosterone, therapy, update, zoledronic acid | Leave a comment »
In another severe setback for the application of immunotherapy in the treatment of advanced prostate cancer, Cell Genesys has announced the early termination of the Phase III VITAL-2 clinical trial comparing GVAX + docetaxel to docetaxel + prednisone. … READ MORE …
Filed under: Drugs in development, Treatment | Tagged: cancer, GVAX, news, prostate, update | 2 Comments »
ImClone Systems has announced the initiation of enrollment of patients with androgen-independent prostate cancer (AIPC) in a Phase II clinical trial with either IMC-A12 or IMC-1121B plus mitoxantrone and prednisone. … READ MORE …
Filed under: Drugs in development, Management, Treatment | Tagged: cancer, IMC-1121B, IMC-A12, news, prostate, update | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 